Ziftomenib and Triptorelin: Interaction Details

Brand names
Ziftomenib
Komzifti
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Triptorelin

We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →

What Happens When You Take Ziftomenib With Triptorelin

What can happen when they are taken together (rated Major)

An increased risk of and an increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Ziftomenib should not be given together with other medications known to have the potential to lengthen the . When using them together is unavoidable, monitoring is needed at the start of combined therapy, throughout the period of , and whenever clinically indicated.

Ziftomenib should be interrupted if the QTc interval exceeds 500 ms or if it rises by more than 60 ms from baseline. Combined use may also lead to adverse reactions linked to QTc prolongation, such as torsades de pointes, other serious , and sudden death.1

The Ziftomenib and Triptorelin Interaction, Explained

Both triptorelin (a hormone-lowering medicine, often used for prostate cancer) and ziftomenib (a leukemia medicine) can affect the heart's electrical rhythm. Each can lengthen the "," a part of the heartbeat cycle seen on an . Taken together, the effect could add up. This could raise the chance of a dangerous irregular heartbeat called , which may cause fainting or, rarely, sudden death.

This concern is based on how the drugs are expected to act, not on reports from patients. Please keep taking both as prescribed and talk with your pharmacist or doctor. Your care team can check your heart with ECGs and adjust your plan if needed. Tell them right away about fainting, dizziness, or a racing or pounding heartbeat.

Interaction: () between triptorelin (GnRH , androgen deprivation associated with QT prolongation) and ziftomenib (menin with QTc prolongation risk). Risk of , other serious , and sudden death.

  • Evidence: Theoretical; no PK interaction implied. Onset unspecified. Severity on file: major.
  • Management: Avoid where possible. If unavoidable, obtain ECGs at initiation, during concomitant use, and as clinically indicated.
  • Interrupt ziftomenib if is greater than 500 ms or change from baseline is greater than 60 ms.
  • Consider correcting electrolytes (K, Mg, Ca) and reviewing other QT-prolonging agents.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Ziftomenib and Triptorelin Interact

The likely mechanism


In short: Ziftomenib and triptorelin both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Ziftomenib and Triptorelin Interaction

The safest approach is to avoid combining these medicines when possible. If your team decides you need both, they will usually plan extra heart monitoring.

  • Your care team may check an before you start the combination, while you take it, and whenever it seems needed.
  • If your ECG shows a heart rhythm change beyond set limits, your team may pause ziftomenib.
  • Keep taking both medicines as prescribed unless your care team tells you otherwise.
  • Tell your pharmacist or prescriber about all your medicines, and report fainting, dizziness, palpitations, or seizures right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Ziftomenib or Triptorelin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Ziftomenib and Triptorelin: Common Questions

How serious is the Ziftomenib and Triptorelin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Ziftomenib and Triptorelin interaction managed?

The safest approach is to avoid combining these medicines when possible. If your team decides you need both, they will usually plan extra heart monitoring. Your care team may check an before you start the combination, while you take it, and whenever it seems needed. If your ECG shows a heart rhythm change beyond set limits, your team may pause ziftomenib. Keep taking both medicines as prescrib… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Ziftomenib and Triptorelin Interaction

Ask in your own words about taking Ziftomenib and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: KOMZIFTI™ oral capsules, ziftomenib oral capsules. Kura Oncology, Inc (per manufacturer), San Diego, CA, 2025. DailyMed
Was this write-up helpful?

Other Serious Interactions of Ziftomenib and Triptorelin

Also serious with Triptorelin

Also serious with Ziftomenib

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.